Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Studies skin bacteria in atopic dermatitis patients receiving systemic therapy

Observes how skin bacteria change in adults with eczema on whole-body treatment.

Plain-language title generated from the registry record
Registry title: Microbiome in Atopic Dermatitis Under Systemic Therapy

Key facts

Where
Berlin, GermanySee the site

Where in Germany

  • Dpt of Dermatology and Allergology, Charité - Universitätsmedizin BerlinBerlin, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Charite University, Berlin, Germany
Trial code
NCT05099315
Record updated
22 October 2026
Original description
The skin microbiome plays a role in the pathogenesis of atopic dermatitis. However, it is unclear whether the range of microbiota on the skin is the cause or consequence of atopic skin inflammation.Read full original descriptionShow less

Identification of Skin-associated Microbiota in Atopic Dermatitis Patients Undergoing Systemic Therapy

The skin microbiome plays a role in the pathogenesis of atopic dermatitis. However, it is unclear whether the range of microbiota on the skin is the cause or consequence of atopic skin inflammation.

The influence of new systemic therapies for the treatment of moderate to severe atopic dermatitis (such as biologics or Janus kinase inhibitors) on the skin microbiome is largely unknown.

The main aim of this scientific exploratory study is to investigate whether and how the skin microbiome changes in patients with moderate to severe atopic dermatitis during systemic therapy. This not only allows new hypotheses to be generated on the pathogenesis of atopic dermatitis, but also new objective scales for the severity of atopic dermatitis can be developed.

Inclusion: Patients with moderate to severe atopic dermatitis; Indication for systemic therapy.

Exclusion: Patients under 18 years of age upon introducing systemic therapy; Pregnant and lactating women.

ClinicalTrials.gov NCT05099315